227 related articles for article (PubMed ID: 18385071)
21. Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages.
Kim YG; Park JH; Daignault S; Fukase K; Núñez G
J Immunol; 2008 Sep; 181(6):4340-6. PubMed ID: 18768892
[TBL] [Abstract][Full Text] [Related]
22. NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae.
Ajendra J; Specht S; Ziewer S; Schiefer A; Pfarr K; Parčina M; Kufer TA; Hoerauf A; Hübner MP
Sci Rep; 2016 Dec; 6():39648. PubMed ID: 28004792
[TBL] [Abstract][Full Text] [Related]
23. Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.
Rosenzweig HL; Jann MM; Glant TT; Martin TM; Planck SR; van Eden W; van Kooten PJ; Flavell RA; Kobayashi KS; Rosenbaum JT; Davey MP
J Leukoc Biol; 2009 Apr; 85(4):711-8. PubMed ID: 19129483
[TBL] [Abstract][Full Text] [Related]
24. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
Kamboj A; Patil MT; Petrovsky N; Salunke DB
Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
[TBL] [Abstract][Full Text] [Related]
26. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
Takada S; Saito MK; Kambe N
G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
[TBL] [Abstract][Full Text] [Related]
27. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation.
Marina-García N; Franchi L; Kim YG; Hu Y; Smith DE; Boons GJ; Núñez G
J Immunol; 2009 Apr; 182(7):4321-7. PubMed ID: 19299732
[TBL] [Abstract][Full Text] [Related]
28. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.
Martin TM; Zhang Z; Kurz P; Rosé CD; Chen H; Lu H; Planck SR; Davey MP; Rosenbaum JT
Arthritis Rheum; 2009 Feb; 60(2):611-8. PubMed ID: 19180500
[TBL] [Abstract][Full Text] [Related]
29. Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages.
Ahn KB; Jeon JH; Baik JE; Park OJ; Kang SS; Yun CH; Park JH; Han SH
Microbes Infect; 2014 Feb; 16(2):153-60. PubMed ID: 24211871
[TBL] [Abstract][Full Text] [Related]
30. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway.
Luo X; Wang X; Huang S; Xu B; Luo S; Li Y; Wang Q; Chen Y; Deng X; Liu L; Zhou L
Int Immunopharmacol; 2021 Jan; 90():107224. PubMed ID: 33302036
[TBL] [Abstract][Full Text] [Related]
31. MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.
Pan Q; Mathison J; Fearns C; Kravchenko VV; Da Silva Correia J; Hoffman HM; Kobayashi KS; Bertin J; Grant EP; Coyle AJ; Sutterwala FS; Ogura Y; Flavell RA; Ulevitch RJ
J Leukoc Biol; 2007 Jul; 82(1):177-83. PubMed ID: 17403772
[TBL] [Abstract][Full Text] [Related]
32. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V
Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575
[TBL] [Abstract][Full Text] [Related]
34. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
[TBL] [Abstract][Full Text] [Related]
35. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
Nakano M; Kambe N
Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
[TBL] [Abstract][Full Text] [Related]
36. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
37. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.
Tanabe T; Chamaillard M; Ogura Y; Zhu L; Qiu S; Masumoto J; Ghosh P; Moran A; Predergast MM; Tromp G; Williams CJ; Inohara N; Núñez G
EMBO J; 2004 Apr; 23(7):1587-97. PubMed ID: 15044951
[TBL] [Abstract][Full Text] [Related]
38. Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.
Chen K; Zhang L; Huang J; Gong W; Dunlop NM; Wang JM
J Leukoc Biol; 2008 Jun; 83(6):1467-75. PubMed ID: 18299458
[TBL] [Abstract][Full Text] [Related]
39. The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.
Grimes CL; Ariyananda Lde Z; Melnyk JE; O'Shea EK
J Am Chem Soc; 2012 Aug; 134(33):13535-7. PubMed ID: 22857257
[TBL] [Abstract][Full Text] [Related]
40. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
Girardin SE; Boneca IG; Viala J; Chamaillard M; Labigne A; Thomas G; Philpott DJ; Sansonetti PJ
J Biol Chem; 2003 Mar; 278(11):8869-72. PubMed ID: 12527755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
